Question Everything. See who's reporting it.

High Court continues Ribociclib case after petitioner's death

Source: Indian Express

The story in brief

The original petitioner died during litigation, prompting the High Court to continue proceedings suo motu due to public interest. The case, concerning Ribociclib's high cost and patent protection, has been listed 57 times without final hearing, with a hearing scheduled for July 15, 2026. The Working Group on Access to Medicines and Treatment highlights the devastating human cost of judicial delays in accessing lifesaving drugs.

4 outletsSee what the other 3 outlets said

NEWXFree on Android and iPhone. Open in NEWX